1-20 of 2132
cytogenetics
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia

Danika Di Giacomo, Roberta La Starza, Paolo Gorello, Fabrizia Pellanera, Zeynep Kalender Atak, Kim De Keersmaecker, Valentina Pierini, Christine J. Harrison, Silvia Arniani, Martina Moretti, Nicoletta Testoni, Giovanna De Santis, Giovanni Roti, Caterina Matteucci, Renato Bassan, Peter Vandenberghe, Stein Aerts, Jan Cools, Beat Bornhauser, Jean-Pierre Bourquin, Rocco Piazza, Cristina Mecucci
Journal: Blood
Blood (2021) 138 (9): 773–784.
https://doi.org/10.1182/blood.2020010510
Published: 2021
Includes: Supplemental data
Journal Articles

Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy

CME Clinical Trials & Observations
Raphael Itzykson, Elise Fournier, Céline Berthon, Christoph Röllig, Thorsten Braun, Alice Marceau-Renaut, Cécile Pautas, Olivier Nibourel, Emilie Lemasle, Jean-Baptiste Micol, Lionel Adès, Delphine Lebon, Jean-Valère Malfuson, Lauris Gastaud, Laure Goursaud, Emmanuel Raffoux, Kevin-James Wattebled, Philippe Rousselot, Xavier Thomas, Sylvain Chantepie, Thomas Cluzeau, Hubert Serve, Nicolas Boissel, Christine Terré, Karine Celli-Lebras, Claude Preudhomme, Christian Thiede, Hervé Dombret, Claude Gardin, Nicolas Duployez
Journal: Blood
Blood (2021) 138 (7): 507–519.
https://doi.org/10.1182/blood.2021011103
Published: 2021
Includes: Supplemental data
Journal Articles

Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia

Clinical Trials & Observations
Mohamed L. Sorror, Barry E. Storer, Amir T. Fathi, Andrew Brunner, Aaron T. Gerds, Mikkael A. Sekeres, Sudipto Mukherjee, Bruno C. Medeiros, Eunice S. Wang, Pankit Vachhani, Paul J. Shami, Esteban Peña, Mahmoud Elsawy, Kehinde Adekola, Selina Luger, Maria R. Baer, David Rizzieri, Tanya M. Wildes, Jamie Koprivnikar, Julie Smith, Mitchell Garrison, Kiarash Kojouri, Wendy Leisenring, Lynn Onstad, Jennifer E. Nyland, Pamela S. Becker, Jeannine S. McCune, Stephanie J. Lee, Brenda M. Sandmaier, Frederick R. Appelbaum, Elihu H. Estey
Journal: Blood
Blood (2021) 138 (5): 387–400.
https://doi.org/10.1182/blood.2020008812
Published: 2021
Includes: Supplemental data
Journal Articles

Leukemia secondary to myeloproliferative neoplasms

Andrew J. Dunbar, Raajit K. Rampal, Ross Levine
Journal: Blood
Blood (2020) 136 (1): 61–70.
https://doi.org/10.1182/blood.2019000943
Published: 2020
Journal Articles

Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

CME
Elise Chapiro, Elodie Pramil, M’boyba Diop, Damien Roos-Weil, Clémentine Dillard, Clémentine Gabillaud, Karim Maloum, Catherine Settegrana, Lucile Baseggio, Jean-François Lesesve, Mélanie Yon, Ludovic Jondreville, Claude Lesty, Frédéric Davi, Magali Le Garff-Tavernier, Nathalie Droin, Philippe Dessen, Caroline Algrin, Véronique Leblond, Jean Gabarre, Simon Bouzy, Virginie Eclache, Baptiste Gaillard, Evelyne Callet-Bauchu, Marc Muller, Christine Lefebvre, Nathalie Nadal, Antoine Ittel, Stéphanie Struski, Marie-Agnès Collonge-Rame, Benoit Quilichini, Sandra Fert-Ferrer, Nathalie Auger, Isabelle Radford-Weiss, Lena Wagner, Sebastian Scheinost, Thorsten Zenz, Santos A. Susin, Olivier A. Bernard, Florence Nguyen-Khac
Journal: Blood
Blood (2019) 134 (21): 1821–1831.
https://doi.org/10.1182/blood.2019001187
Published: 2019
Includes: Supplemental data
Journal Articles

Azacitidine (AZA) with Nivolumab (Nivo), and AZA with Nivo + Ipilimumab (Ipi) in Relapsed/Refractory Acute Myeloid Leukemia: A Non-Randomized, Prospective, Phase 2 Study

Naval G. Daver, MD, Guillermo Garcia-Manero, MD, Marina Y Konopleva, MD PhD, Mansour Alfayez, MDMS, Naveen Pemmaraju, MD, Tapan M. Kadia, MD, Courtney D. DiNardo, MD MSc, Jorge E. Cortes, MD, Farhad Ravandi, MD, Hussein Abbas, MD BS, Sreyashi Basu, PhD, Elias Jabbour, MD, Sherry A. Pierce, BSN, BA, Zeev E. Estrov, MD, Koichi Takahashi, MD, Jing Ning, PhD, Steven M. Kornblau, MD, Koji Sasaki, MD, Lucia Masarova, MD, Wilmer Flores, James P Allison, PhD, Padmanee Sharma, MD PhD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 830.
https://doi.org/10.1182/blood-2019-131494
Published: 2019
Journal Articles

Prognostic Impact of Clonal Diversity in Acute Myeloid Leukemia (AML) Treated with Intensive Chemotherapy (IC)

Marco Cerrano, MD, Marie Passet, PharmD, Loic Vasseur, MD, Pierre Hirsch, MD PhD, Xavier Thomas, MD PhD, Samuel Quentin, Justine Pasanisi, Florence Rabian, MD, Ramy Rahmé, MD, Etienne Lengline, MD, Emmanuel Raffoux, MD, Nathalie Dhedin, MD, Marie Sebert, MD, Odile Maarek, Anna Raimbault, PhD, Karine Celli-Lebras, CRA, Lionel Ades, MD PhD, Pierre Fenaux, MD PhD, Nicolas Boissel, MD PhD, Francois Delhommeau, MD PhD, Jean Soulier, MD PhD, Herve Dombret, MD PhD, Emmanuelle Clappier, PhD PharmD, Pierre Sujobert, MD PhD, Raphael Itzykson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2700.
https://doi.org/10.1182/blood-2019-127475
Published: 2019
Journal Articles

Choice of Hypomethylating Agent (HMA) for Initial Treatment Does Not Influence Outcome or Survival for Therapy-Related Myeloid Neoplasms (t-MN)

Charlene C. Kabel, PharmD, Debra A. Goldman, MS, Larry W. Buie, PharmD, BCOP, FASHP, Virginia M. Klimek, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1718.
https://doi.org/10.1182/blood-2019-129129
Published: 2019
Journal Articles

Influence of Cytogenetics in Patients with Relapsed Refractory Multiple Myeloma Treated with Oral Selinexor and Dexamethasone: A Post-Hoc Analysis of the STORM Study

Ajay K Nooka, MDMPH, Andrew J. Yee, MD, Carol Ann Huff, MD, Dan T. Vogl, MD, Maria Gavriatopoulou, MD, Ajai Chari, MD, Philippe Moreau, MD, David Dingli, MD PhD, Craig E. Cole, MD, Sagar Lonial, Meletios A. Dimopoulos, MD, Joshua R Richter, MD, Ravi Vij, MBBS, Sascha A Tuchman, MD, Marc S Raab, MD PhD, Noa Biran, MD, David S. Siegel, Paul G. Richardson, MD, Jianjun Liu, Anita Joshi, PhD, Jatin Shah, MD, Sharon Shacham, PhD MBA, Michael G. Kauffman, MD PhD, Sundar Jagannath, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1872.
https://doi.org/10.1182/blood-2019-122908
Published: 2019
Journal Articles

The Disease-Risk Stratification Scheme (DRSS), a Contemporary Risk-Stratification System for Allogeneic Stem Cell Transplantation

Roni Shouval, Joshua A Fein, MD, Myriam Labopin, MD, Ali Bazarbachi, MD PhD, Frédéric Baron, MD PhD, Gesine Bug, Fabio Ciceri, MD, Selim Corbacioglu, MD, Sebastian Giebel, MD PhD, Maria H Gilleece, MD FRCPath, MB, BSc, FRCP, Silvia Montoto, MD, Zinaida Peric, MD PhD, Emmanuelle Polge, M.Sc, Annalisa Ruggeri, MD, Jaime Sanz, MDPhD, Bipin N. Savani, MD, Christoph Schmid, MD, Alexandros Spyridonidis, MD PhD, Jurjen Versluis, MD PhD, Ibrahim Yakoub-Agha, MD PhD, Mohamad Mohty, MD PhD, Arnon Nagler, MD MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 43.
https://doi.org/10.1182/blood-2019-123310
Published: 2019
Journal Articles

A Personalized Prediction Model to Risk Stratify Patients with Acute Myeloid Leukemia (AML) Using Artificial Intelligence

Jacob Shreve, MD MS, Manja Meggendorfer, PhD, Hassan Awada, MD, Sudipto Mukherjee, MD PhD MPH, Wencke Walter, PhD, Stephan Hutter, PhD, Ahed Makhoul, MD, Cameron Beau Hilton, BA, Nathan Radakovich, BA, Yasunobu Nagata, MD PhD, Yazan Rouphail, Vera Adema, PhD, Cassandra M Kerr, MS, Bhumika J. Patel, MD, Teodora Kuzmanovic, Jaroslaw P. Maciejewski, MD PhD, Claudia Haferlach, MD, Mikkael A. Sekeres, MD MS, Torsten Haferlach, MD, Aziz Nazha, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2091.
https://doi.org/10.1182/blood-2019-128066
Published: 2019
Journal Articles

Reevaluating the Role of Cytogenetic Testing in Patients with Suspected Myelodysplastic Syndrome in the Era of Next Generation Sequencing

Eri Kawata, MD PhD, Anargyros Xenocostas, MD FRCPC, Cyrus C. Hsia, MDBSc,FRCPC, Alejandro Lazo-Langner, MD MSc, Kang Howson-Jan, MD FRCPC, Uday Deotare, MBBS, MD DM, Lalit Saini, MD, Benjamin Hedley, PhD, Ping Yang, PhD DABMGG, Michael Levy, PhD, Hanxin Lin, PhD, Bekim Sadikovic, PhD DABMGG, FACMG, Ian Chin-Yee, MD FRCPC
Journal: Blood
Blood (2019) 134 (Supplement_1): 3438.
https://doi.org/10.1182/blood-2019-128507
Published: 2019
Journal Articles

Cytogenetic and Molecular Response with First- and Second-Generation Tyrosine Kinase Inhibitor (TKI) Therapy in Simplicity: An Observational Study of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML)

Jorge E. Cortes, MD, Clara Chen, PhD BS, MS, Catherine Davis, PharmD, Stuart L. Goldberg, MD, Michael J. Mauro, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2929.
https://doi.org/10.1182/blood-2019-127959
Published: 2019
Journal Articles

Patient Specific Comorbidities Impact Overall Survival in Myelofibrosis

Andrew Sochacki, MD, Cosmin Adrian Bejan, PhD, Shilin Zhao, PhD, Travis Spaulding, MD, Shannon Stockton, MD, Alexander Silver, Dixon Dorand, MD PhD, Siwei Zhang, PhD, Thomas Stricker, MD PhD, Yaomin Xu, PhD, Michael R. Savona, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2959.
https://doi.org/10.1182/blood-2019-121513
Published: 2019
Journal Articles

Clinical-Grade Whole Genome Sequencing Reproduces FISH Cytogenetics and Provides Actionable Data in Newly Diagnosed Myeloma - a Pilot Study from the UK 100,000 Genomes Project

Oliver Lomas, MD DPhil, MRCP, Sarah Gooding, MD PhD, Karthik Ramasamy, MD PhD, Angela Hamblin, MD PhD, Maite Cabes, PhD, Helene Marie-Pierre Dreau, PhD, Edward Wilson, FRCPath, MRCP
Journal: Blood
Blood (2019) 134 (Supplement_1): 3062.
https://doi.org/10.1182/blood-2019-125145
Published: 2019
Journal Articles

High Risk Cytogenetic and Immunohistochemistry Findings in Monomorphic Post-Transplant Lymphoproliferative Disorder Following Solid Organ Transplant - a Single Center Experience

Timothy J Voorhees, MD, Natalie S Grover, MD, Jonathan Galeotti, MD MS, Nathan D Montgomery, MD, Dominic T. Moore, MPH, MS, Anne Beaven, MD, Christopher Dittus, DO
Journal: Blood
Blood (2019) 134 (Supplement_1): 2915.
https://doi.org/10.1182/blood-2019-126228
Published: 2019
Journal Articles

TP53 Status As Well As Cytogenetic Complexity Significantly Impact on Prognosis in Myelodysplastic Syndromes with Complex (≥3 anomalies) Aberrant Karyotypes

Christina Ganster, Roxana Schaab, Katayoon Shirneshan, Lea Naomi Eder, Anna Mies, Ulrich Germing, MD, Ahmet Elmaagacli, Francesc Sole, PhD, Laura Palomo, Jennifer Kaivers, MD, Ulrike Söling, Frank Lange, Nicolaus Kröger, Bernd Hertenstein, Konstanze Döhner, Gesine Bug, Barbara Hildebrandt, Marc Talló Parra, Maike Nickelsen, Bertram Glass, Uwe Platzbecker, MD, Ulrike Bacher, Friederike Braulke, Julie Schanz, MD PhD, Detlef Haase, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3007.
https://doi.org/10.1182/blood-2019-126671
Published: 2019
Journal Articles

The Clinical Application of Oncomine Myeloid Next Generation Sequencing (NGS): Comparison of Cytogenetics and NGS in Patients with Suspected Myelodysplastic Syndrome

Eri Kawata, MD PhD, Anargyros Xenocostas, MD FRCPC, Cyrus C. Hsia, MDBSc,FRCPC, Uday Deotare, MBBS, MD DM, Lalit Saini, MD, Ping Yang, PhD DABMGG, Michael Levy, PhD, Hanxin Lin, PhD, Bekim Sadikovic, PhD DABMGG, FACMG, Ian Chin-Yee, MD FRCPC
Journal: Blood
Blood (2019) 134 (Supplement_1): 3375.
https://doi.org/10.1182/blood-2019-126893
Published: 2019
Journal Articles

Coagulation FXIII-a Protein Expression Defines Three Novel Sub-Populations in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia Characterized By Distinct Gene Expression Signatures

Katalin Gyurina, MSc, BSc, Bettina Kárai, MD PhD, Anikó Ujfalusi, MD PhD, Zsuzsanna Hevessy, MD PhD, Gábor Barna, PhD, Pál Jáksó, MD PhD, Gyönygi Pálfi-Mészáros, Szilárd Páliska, PhD, Beáta Scholtz, PhD, János Kappelmayer, MD PhD DSc, Gábor Zahuczky, PhD, Csongor Kiss, MD PhD DSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 2523.
https://doi.org/10.1182/blood-2019-124333
Published: 2019
Journal Articles

Recurrent Gene Mutations in Pediatric Patients with AML By Targeted Sequencing ―the Jccg Study, JPLSG AML-05―

Taeko Kaburagi, MD, Genki Yamato, MD PhD, Norio Shiba, Kenichi Yoshida, MD PhD, Yusuke Hara, Yuichi Shiraishi, PhD, Kentaro Ohki, MD PhD, Manabu Sotomatsu, MD PhD, Hirokazu Arakawa, MD PhD, Hidemasa Matsuo, PhD, Akira Shimada, MD PhD, Tomohiko Taki, MD PhD, Nobutaka Kiyokawa, MD PhD, Daisuke Tomizawa, MD PhD, Keizo Horibe, MD PhD, Satoru Miyano, PhD, Takashi Taga, MD PhD, Souichi Adachi, MD PhD, Seishi Ogawa, MD PhD, Yasuhide Hayashi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2697.
https://doi.org/10.1182/blood-2019-126545
Published: 2019